You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
公司問答 | 雲南白藥:協同萬隆控股重新構架進出口業務體系
格隆匯 04-18 20:08
格隆匯4月18日丨有投資者在互動平台向雲南白藥公司提問:請問公司海外銷售的有哪些產品?CBD業務是否還在開展?雲南白藥迴應:公司協同萬隆控股重新構架進出口業務體系,對核心客户的需求進行分析挖掘,積極爭取白藥系列產品及已出口品種的訂單恢復;在蜂蠟、跨境電商、益生菌等業務基礎上,圍繞天然植物提取物領域拓展了多個品種進出口業務。公司對CBD業務的定位,是面向海外市場,主要是聚焦醫用、藥用方面。公司已完成“CBD研究中心”掛牌,獲得《雲南省CBD科研種植許可證》,為後續合法開展CBD產業相關業務提供資質保障,也有助於未來培育優勢CBD新品種,不斷優化工藝,提升原料競爭力,公司也將密切關注國家及地方相關法律法規的最新動態,結合國際市場,穩步開展相關業務。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account